Torrey Pines Law GroupFree Consultation
≡
  • About Us
    • About Our Firm
    • The Advantages of Hiring Our Firm
    • Recent Successes
    • Client Testimonials
    • Careers
    • Diversity, Equity & Inclusion
    • Locations
    • Boston
      • Boston Patent Atorneys
      • Boston FDA Regulatory Counsel
      • Boston Technology Transactions
    • Irvine
      • Irvine Patent Atorneys
      • Irvine FDA Regulatory Counsel
      • Irvine Technology Transactions
    • Los Angeles
      • Los Angeles Patent Atorneys
      • Los Angeles FDA Regulatory Counsel
      • Los Angeles Technology Transactions
    • San Diego
      • San Diego Patent Atorneys
      • San Diego FDA Regulatory Counsel
      • San Diego Technology Transactions
    • Contact
  • Professionals
    • Meet Our Team
    • Randy Berholtz, MLitt, MBA, JD
    • Robert Buchanan, PhD, JD
    • Kevin Buckley, JD
    • Frank Chen, PhD
    • Doranne Frano, MS, MBA
    • Dmitry Kryndushkin, PhD
    • Mark Malek, JD
    • James McFarland, JD
    • Eleanor Musick, JD
    • Shihong Nicolaou, PhD
    • Steven Stupp, PhD
    • Kyle Welch, JD
    • Fawn Zhang, PharmD, JD
    •  
    • Administration
    • Jaenna Barnard
    • Carina Collins
    • Amy Stedman
    • Cyndi Willis
    •  
    • Foreign Associates
  • Intellectual Property
    • Comprehensive IP Protection
    • Patent Preparation & Prosecution
    • ● Artificial Intelligence Patents
    • ● Biotechnology Patents
    • ● Chemistry Patents
    • ● Convergence Technology Patents
    • ● In Vitro Diagnostics Patents
    • ● Lasers & Optics Patents
    • ● Medical Device Patents
    • ● Pharmaceutical Patents
    • ● Pharmaceutical Lifecycle Management
    • ● Semiconductor Patents
    • ● Software Patents
    • ● Telecommunications Patents
    • ● Telemedicine Patents
    • National Phase Entry (PCT)
    • IP Litigation
    • IP Opinions & Counseling
    • IP Resources
      • Patent Rights Overview
      • International Patent Law
      • U.S. Patent Law
        • Patent Eligibility
        • Novelty
        • Obviousness
        • Written Description
        • Enablement
      • Anatomy of a U.S. Patent
        • Utility Patent
        • Design Patent
        • Plant Patent
      • Trademark Law
      • Copyright Law
      • Trade Secrets
      • Know How
      • Intangible Assets
  • Tech Transactions
    • International Technology Transactions
    • Corporate Strategy
    • Business Agreements
    • Transactional Due Diligence
    • Intellectual Property Agreements
    • Intellectual Property Due Diligence
    • Regulatory Agreements
    • Regulatory Due Diligence
  • FDA Regulatory
    • Global Strategic Counseling
    • Dossier Submissions
    • Quality Compliance (ISO)
    • CE Mark - MDR Services
    • Digital Health
    • Hatch-Waxman & Biosimilars
    • Labeling, Advertising & Promotion
    • Reimbursement & Health Economics
  • Experience
    • Our International Experience
    • Multinational Companies
    • Public Companies
    • Private Companies
    • Research & Academic Institutions
    • Hospitals & Physicians
    • Startups & Entrepreneurs
  • Contact
background
Hide
 
Show
  • background
  • torrey-pines-broken-hill
  • torrey-pines-sunset
Dmitry Kryndushkin

Dmitry Kryndushkin, Ph.D.

US Patent Agent

dmitry@torreypineslaw.com
main: +1 (858) 869-1250

Dmitry is an accomplished patent agent having significant scientific and regulatory expertise in the biotechnology, pharmaceutical, medical, chemical, IT and mechanical arts. Dmitry’s experience includes working as a Director, Intellectual Property for a biotechnology company, where he has been involved in all aspects of patenting, including soliciting new inventions, drafting patent application, performing prosecution in the US and abroad, and managing strategic development of the IP portfolio. Dmitry’s prior experience includes working for several years in a highly-regarded law firm where he prepared and prosecuted a multitude of utility patent applications in both the United States and internationally. He has coordinated the preparation and prosecution of patent applications in many foreign jurisdictions, and has contributed to preparation of Freedom-to-Operate and patentability opinions for his clients.

Dmitry was included in the IAM Patent 1000-The World's Leading Patent Professionals (2019-2020). He also served as a primary reviewer of U.S. PCT patent applications related to biotechnology and pharmaceutical inventions, preparing International Search Reports and Written Opinions.

Dmitry has extensive research experience in the life sciences and healthcare fields and is an author of more than 30 peer-reviewed publications in international journals. He was a regulatory scientist at the U.S. Food and Drug Administration (FDA, Center for Drug Evaluation and Research, Office of Biotechnology Products), evaluating potential problems that therapeutic proteins may face during manufacturing and storage. Before that, he was a postdoctoral scientist at the National Institutes of Health (NIH) and at the Uniformed Services University of the Health Sciences.

Dmitry is registered to practice before the U.S. Patent & Trademark Office. He holds a Ph.D. degree in Molecular Biophysics from the Moscow Institute of Physics and Technology (MIPT), Russia, and received a B.S., Applied Mathematics and Physics from MIPT, with honors. He obtained a Regulatory Affairs Certification from Regulatory Affairs Professional Society showing general knowledge about regulations of drugs, biologics and medical devices.

≡
  • Meet Our Team
  • Randy Berholtz, MLitt, MBA, JD
  • Robert Buchanan, PhD, JD
  • Kevin Buckley, JD
  • Frank Chen, PhD
  • Doranne Frano, MS, MBA
  • Dmitry Kryndushkin, PhD
  • Mark Malek, JD
  • James McFarland, JD
  • Eleanor Musick, JD
  • Shihong Nicolaou, PhD
  • Steven Stupp, PhD
  • Kyle Welch, JD
  • Fawn Zhang, PharmD, JD
  •  
  • Administration
  • Jaenna Barnard
  • Carina Collins
  • Amy Stedman
  • Cyndi Willis
  •  
  • Foreign Associates

Chambers Spotlight California 2025 Torrey Pines Law Group   Clio Reisman Award Torrey Pines Law Group COPYRIGHT © , TORREY PINES LAW GROUP, PC. ALL RIGHTS RESERVED. | LEGAL NOTICES | SITE MAP

Torrey Pines Law Group, PC serves technology innovators with protecting intellectual property, obtaining regulatory approvals and clearances, and making deals and closing technology transactions throughout the U.S., including in major technology hubs such as San Diego, San Francisco, Palo Alto, San Jose, Silicon Valley, Boston, Cambridge, Chicago, Minneapolis, Houston, Dallas, Atlanta, Denver, Seattle, Portland, Boulder, Orlando, the Research Triangle (Raleigh, Durham, and Chapel Hill), the Mid-Atlantic (New Jersey, New York, Philadelphia, Maryland, Virginia, and Washington, DC), Pittsburgh, Cleveland, Ann Arbor, and throughout Southern California in Los Angeles, Orange County, Irvine, Torrey Pines, Sorrento Valley, and La Jolla.

We have experience with international intellectual property, regulatory and transactional matters pending in Beijing, Shanghai, Shenzhen, and Guangzhou China; Tokyo, Japan; Berlin, Munich and Frankfurt Germany; Tel Aviv Israel; Mumbai, Bengaluru, and New Delhi India; London and Edinburgh United Kingdom; Vancouver, Toronto, Calgary and Montreal Canada; Dublin, Ireland; Cape Town, South Africa; Mexico City and Tijuana Mexico; Brussels, Belgium; Copenhagen, Denmark; Paris, France; Madrid and Barcelona Spain; Moscow, Russia; Santiago, Chile; Montevideo, Uruguay; Buenos Aires, Argentina; Sao Paulo and Rio de Janeiro Brazil; Seoul, South Korea; Taipei, Taiwan; Hong Kong; Hanoi, Vietnam; Bangkok, Thailand; Kuala Lumpur, Malaysia; Milan, Italy; Singapore; Sydney, Melbourne, Perth and Adelaide Australia; Auckland, New Zealand; Oslo, Norway; Stockholm, Sweden; Helsinki, Finland; Kiev, Ukraine; Budapest, Hungary; Vienna, Austria; Prague, Czechia; Geneva and Lausanne Switzerland; Bahrain; Doha, Qatar; Abu Dhabi and Dubai UAE; and Jeddah, Saudi Arabia.

Biotechnology Patent Agent - San Diego FDA Regulatory - Biopharmaceutical Patent Preparation & Prosecution Lawyer - Small Molecule Pharmaceutical Intellectual Property Opinions - Complex FDA Regulatory Due Diligence